Cognitive Decline in Preclinical Stage 2 Alzheimer Disease and Implications for Prevention Trials
JAMA Neurol
.
2016 Jun 1;73(6):640-2.
doi: 10.1001/jamaneurol.2016.0281.
Authors
Elizabeth C Mormino
1
,
Kathryn V Papp
2
Affiliations
1
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston.
2
Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
PMID:
27064971
DOI:
10.1001/jamaneurol.2016.0281
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Alzheimer Disease*
Cognitive Dysfunction*
Disease Progression
Humans
Neuropsychological Tests
Grants and funding
F32 AG044054/AG/NIA NIH HHS/United States
P01 AG036694/AG/NIA NIH HHS/United States